Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Rigorous nationwide population-based cohort study with large sample, long follow-up, and multivariable adjustment demonstrates clear associations between thyroidectomy/thyroid hormone therapy and multiple metabolic outcomes; not practice-changing because it establishes risk rather than testing an intervention to mitigate it.
A single-centre retrospective study with modest sample size identifying predictive biomarkers for radioiodine response using immunohistochemistry and mutation analysis; results are encouraging but require validation in an independent cohort before clinical adoption.
This is a narrative review synthesizing experimental animal studies and emerging translational work on 3,5-T2; it raises mechanistic questions and identifies knowledge gaps rather than reporting a definitive clinical result or trial outcome.
Single-center retrospective cohort with internal validation only; machine-learning models show promising discrimination but lack external validation and prospective confirmation required to establish clinical utility.
This is a descriptive portfolio analysis of research funding trends using administrative data; it characterizes what has been funded rather than testing clinical or scientific hypotheses, and generates no outcome data or efficacy evidence.
This is a comprehensive narrative review synthesizing existing literature on extracellular vesicles in thyroid cancer, identifying methodological challenges and future directions rather than presenting new empirical evidence or clinical outcomes.
Single-centre retrospective cohort study with clinical endpoints (PFS, OS) in a defined population, showing statistically significant associations, but limited by retrospective design, lack of mechanistic validation, and absence of external validation.
Single-centre scRNA-seq descriptive study of 11 tumours with small LT subgroup, identifying immune mechanisms without functional validation or clinical outcome prediction.